OncoSec Medical Inc. (ONCS) Short Interest Update
OncoSec Medical Inc. (NASDAQ:ONCS) was the recipient of a significant increase in short interest in November. As of November 15th, there was short interest totalling 968,903 shares, an increase of 62.6% from the October 31st total of 596,009 shares. Based on an average daily trading volume, of 246,405 shares, the short-interest ratio is currently 3.9 days. Currently, 5.3% of the shares of the stock are sold short.
An institutional investor recently raised its position in OncoSec Medical stock. Vanguard Group Inc. increased its position in shares of OncoSec Medical Inc. (NASDAQ:ONCS) by 3.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 430,031 shares of the company’s stock after buying an additional 13,025 shares during the period. Vanguard Group Inc. owned approximately 2.44% of OncoSec Medical worth $705,000 at the end of the most recent quarter. Institutional investors own 8.31% of the company’s stock.
OncoSec Medical (NASDAQ:ONCS) opened at 1.45 on Tuesday. The firm’s 50-day moving average is $1.70 and its 200-day moving average is $1.72. The firm’s market cap is $27.78 million. OncoSec Medical has a 12 month low of $1.36 and a 12 month high of $3.49.
OncoSec Medical (NASDAQ:ONCS) last issued its earnings results on Thursday, October 13th. The company reported ($0.39) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.32) by $0.07. Equities analysts expect that OncoSec Medical will post ($1.33) earnings per share for the current year.
Separately, Maxim Group reissued a “buy” rating on shares of OncoSec Medical in a report on Wednesday, November 9th.
COPYRIGHT VIOLATION NOTICE: This news story was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another publication, it was illegally copied and republished in violation of international copyright and trademark laws. The original version of this news story can be read at https://www.thecerbatgem.com/2016/11/29/oncosec-medical-inc-oncs-short-interest-update.html.
About OncoSec Medical
OncoSec Medical Incorporated is a biotechnology company focused on designing, developing and commercializing gene therapies, therapeutics and medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer. The Company’s portfolio includes biologic immunology therapeutic product candidates intended to treat a range of tumor types.
Receive News & Stock Ratings for OncoSec Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OncoSec Medical Inc. and related stocks with our FREE daily email newsletter.